This site is intended for healthcare professionals
News

FDA approves Tembexa for smallpox.- Chimerix

Read time: 1 mins
Last updated:8th Jun 2021
Published:7th Jun 2021
Chimerix announced that the FDA has granted Tembexa (brincidofovir) tablets and oral suspension approval for the treatment of smallpox. Tembexa is approved for adult and pediatric patients, including neonates.
Condition: Smallpox
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest